Aberdeen Group plc Sells 13,590 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Aberdeen Group plc cut its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 45.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,414 shares of the medical instruments supplier's stock after selling 13,590 shares during the period. Aberdeen Group plc owned 0.08% of Mettler-Toledo International worth $19,190,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Zions Bancorporation National Association UT acquired a new stake in Mettler-Toledo International during the 1st quarter worth approximately $43,000. Golden State Wealth Management LLC grew its stake in Mettler-Toledo International by 583.3% in the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after acquiring an additional 35 shares during the last quarter. Menard Financial Group LLC acquired a new stake in shares of Mettler-Toledo International in the fourth quarter valued at approximately $67,000. Blue Trust Inc. lifted its position in shares of Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after acquiring an additional 52 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its stake in Mettler-Toledo International by 39.1% in the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after purchasing an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Stock Performance

Shares of MTD traded up $47.2050 during mid-day trading on Friday, reaching $1,325.2050. 72,260 shares of the company's stock traded hands, compared to its average volume of 173,650. The business's 50-day moving average price is $1,224.30 and its 200-day moving average price is $1,189.23. The stock has a market capitalization of $27.30 billion, a P/E ratio of 33.56, a price-to-earnings-growth ratio of 3.95 and a beta of 1.34. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same period last year, the company posted $9.65 EPS. The firm's quarterly revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analyst Upgrades and Downgrades

MTD has been the topic of a number of recent analyst reports. Bank of America increased their price target on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Robert W. Baird lifted their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Evercore ISI dropped their price objective on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Citigroup increased their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday. Finally, Barclays initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price for the company. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $1,311.11.

Insider Transactions at Mettler-Toledo International

In related news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the sale, the director directly owned 120 shares of the company's stock, valued at $139,191.60. This trade represents a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares of the company's stock, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 2,889 shares of company stock valued at $3,603,054 in the last three months. 1.94% of the stock is currently owned by insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.